Seventure
31 October 2023
MaaT Pharma to Present Preclinical Data at SITC on MaaT034, an Artificial Intelligence-Generated Product Aimed at Improving Patients’ Responses to Immunotherapies
MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotech company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to...
30 October 2023
Enterome Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program
Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry...
26 October 2023
MaaT Pharma Announces Positive Outcome Following DSMB Review Reinforcing Confidence in Phase 3 On-Going Trial in Acute Graft-versus-Host Disease with MaaT013
MaaT Pharma today announced that the DSMB unanimously recommended that the open-label, single arm pivotal Phase 3 clinical trial evaluating MaaT013 in acute Graft-versus-Host...
9 October 2023
CorWave announces the grand opening of its manufacturing facility on the banks of the Seine, next to Paris
A French company that develops and manufactures innovative cardiac assist devices, held the grand opening of its new facility on the banks of the Seine in Clichy, next to...
29 August 2023
Citryll Announces Appointments of Eduardo Bravo as CEO and Tim Schenk as CBO
Citryll, a clinical-stage biotech company developing first-in-class therapeutics to treat immune-mediated inflammatory diseases, today announced the appointment of Eduardo...
24 August 2023
Alliance Promotion Microbiote applauds the new legislation securing stool collection in France
The Alliance Promotion Microbiote (APM), a prominent player dedicated to the development, production, and commercialization of therapeutic microbiome-based innovations,...
1 August 2023
IDnow receives ANSSI’s security approval for PVID certification for its identity proofing services IDCheck.io and VideoIdent
IDnow, a leading identity proofing platform provider in Europe, has obtained the remote identity verification certification known as PVID (prestataire de verification...
12 December 2022
Enterome completes patient enrollment of Phase 2 ROSALIE study evaluating its lead immunotherapy, EO2401, in recurrent glioblastoma
Enterome, a clinical stage company developing first-in-class immunomodulatory drugs based on its gut bacterial Mimicry drug discovery platform, today announces completion of...